ARTICLE | Company News
Centagenetix, Elixir Pharmaceuticals deal
January 13, 2003 8:00 AM UTC
The companies will merge in a stock transaction. The deal combines Elixir’s technology on the biology and molecular genetics of aging and Centagenetix’s population studies to identify and associate ge...